Mirac Ozen
Adapazari, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.
Journal: Immunotherapy
Published: September 02, 2026
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Journal: Future oncology (London, England)
Published: October 17, 2025
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: June 21, 2024
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Journal: Cancer medicine
Published: February 01, 2024
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Journal: BMC cancer
Published: January 23, 2024
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Journal: Scientific reports
Published: December 28, 2023
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Journal: International journal of clinical oncology
Published: July 14, 2023
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Journal: BMC cancer
Published: February 21, 2023
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Journal: Breast (Edinburgh, Scotland)
Published: August 09, 2022
The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 04, 2022
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: May 17, 2022
Last Updated: 09/26/2026